Antitumor potential of a synthetic interferon-alpha/PLGF-2 positive charge peptide hybrid molecule in pancreatic cancer cells

Pancreatic cancer is the most aggressive malignant disease, ranking as the fourth leading cause of cancer-related death among men and women in the United States. Interferon alpha (IFNα) has been used to treat pancreatic cancer, but its clinical application has been significantly hindered due to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Hongmei, Chen, Naifei, Guo, Rui, Wang, Hong, Li, Wei, Wang, Guanjun, Cui, Jiuwei, Jin, Haofan, Hu, Ji-Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653758/
https://www.ncbi.nlm.nih.gov/pubmed/26584517
http://dx.doi.org/10.1038/srep16975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653758/
https://www.ncbi.nlm.nih.gov/pubmed/26584517
http://dx.doi.org/10.1038/srep16975

Ejemplares similares